Oracles, Pentagon

Oracle's Pentagon Deal Fails to Soothe Investors Rattled by a $100 Billion Debt Load

Published on 07/24/2026 at 14:31 | Redaktion boerse-global.de

Oracle's $6.99B Pentagon contract, its largest government IT deal, fails to boost shares as investors focus on $100B+ debt and massive AI capex plans.

Oracle Pentagon Deal Fails to Lift Stock Amid $100B Debt and AI Spending
Oracle's Pentagon Deal Fails to Soothe Investors Rattled by a $100 Billion Debt Load Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

The arithmetic is brutal. Oracle just locked in a $6.99 billion contract with the Pentagon — one of the largest government IT agreements in the company's history — and the stock barely flinched. Shares closed at €105.56 on Thursday, down 4.3% on the day, hovering just 0.48% above a fresh 52-week low of €105.06 set on July 23, the same day the deal was signed. For a company that has lost nearly 48% of its market value over the past twelve months, a seven-billion-dollar vote of confidence from the US Department of Defense should have been a catalyst. It wasn't.

The Pentagon's Enterprise Software Agreement, announced on July 23, 2026, runs for ten years with a five-year base period worth $3.31 billion and an option for an additional five years that brings the total to $6.99 billion. The contract consolidates on-premises software licenses, SaaS offerings, and consulting services for the Department of Defense, the Coast Guard, and the intelligence community under a single framework covering more than 3.4 million personnel. The government estimates the arrangement will save taxpayers at least $441 million. It is the first direct, department-wide on-premises software deal Oracle has ever secured with the Pentagon, following a similar $9.69 billion agreement Microsoft won in May.

For Oracle, the contract validates its "sovereign cloud" strategy at a moment when the company's traditional licensing business is shrinking — down 2% year-over-year in the most recent quarter — while cloud revenue surges 47%. Washington is clearly consolidating its technology modernization around a handful of established hyperscalers, and Oracle now has a seat at that table. The political dimension is hard to ignore: Oracle co-founder Larry Ellison is a known supporter of Donald Trump, and CNBC has noted the deal's political undertones.

But none of that has moved the needle for investors. The stock's Relative Strength Index sits at 29.9, deep in oversold territory, and the technical picture aligns with the fundamental anxiety that has gripped the name for months.

Should investors sell immediately? Or is it worth buying Oracle?

The $100 Billion Question

The market's indifference to the Pentagon deal stems from a single, overwhelming concern: Oracle's balance sheet. The company closed fiscal 2026 with negative free cash flow of $23.7 billion, a direct consequence of the capital spending required to build out AI infrastructure. For fiscal 2027, Oracle plans to invest between $70 billion and $95 billion. To fund that, the company is reportedly seeking roughly $40 billion in new debt, on top of an existing debt load that already exceeds $100 billion.

S&P Global downgraded Oracle to BBB- in early July, and a separate study cited by Benzinga flagged off-balance-sheet liabilities of $273.3 billion at Oracle — part of a broader $1.65 trillion in off-balance-sheet AI debt across the major technology companies. Insider sales totaling $63.7 million over the past three months have done nothing to calm nerves.

The dividend of $0.50 per share, meanwhile, is not fully covered by free cash flow — a warning signal for income-focused investors that is hard to dismiss.

A Market Divided

Analyst targets for Oracle span an extraordinary range. Guggenheim rates the stock a buy with a price target of $400, while CLSA is more cautious at $145 with a hold rating. Mizuho sees potential for the stock to more than double from current levels. The broader consensus sits at a moderate buy with an average target of $265.03 — roughly 2.5 times the current price. In euro terms, the average analyst target is €219.22.

Oracle at a turning point? This analysis reveals what investors need to know now.

The bull case rests on Oracle's $638 billion in remaining performance obligations (RPO), a massive pipeline of future revenue that the Pentagon deal only reinforces. The bear case is simpler: a company with negative free cash flow, a BBB- credit rating, and a debt load that is only getting heavier cannot afford to keep spending at this pace indefinitely. The Pentagon contract, for all its size, is a drop in that ocean.

Oracle is effectively betting that it has become indispensable as the backend for the AI era, particularly for governments and sovereign institutions. The Pentagon deal proves that the US government is willing to place that bet alongside the company. The capital markets, however, are demanding more than contracts. They want to see a path out of the debt spiral before they buy into the lofty price targets.

Ad

Oracle Stock: New Analysis - 24 July

Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Oracle analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US68389X1054 | ORACLES | boerse | 69862666 |